EP 0854884 A1 19980729 - LIGAND INHIBITORS OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS AND METHODS OF USE THEREFOR
Title (en)
LIGAND INHIBITORS OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS AND METHODS OF USE THEREFOR
Title (de)
INHIBITOREN VON LIGANDEN DER INSULIN-ÄHNLICHEN FAKTOR BINDENDEN PROTEINE UND METHODEN FÜR IHRE VERWENDUNG
Title (fr)
INHIBITEURS DE LIGANDS INHIBANT LES PROTEINES DE LIAISON DU FACTEUR DE CROISSANCE DU TYPE INSULINE ET LEURS PROCEDES D'UTILISATION
Publication
Application
Priority
- US 9706503 W 19970417
- US 63393496 A 19960417
Abstract (en)
[origin: WO9739032A1] Methods for increasing the level of free, biologically active proteins, including insulin-like growth factors, and for treating IGF-responsive conditions are provided. The methods generally comprise administering one or more ligand inhibitors that inhibit the binding of the protein to one or more insulin-like growth factor binding proteins. Suitable ligand inhibitors include analogs of IGF-I or IGF-II and small molecule inhibitors.
IPC 1-7
IPC 8 full level
G01N 33/15 (2006.01); A61K 38/00 (2006.01); A61K 45/00 (2006.01); A61P 3/08 (2006.01); A61P 3/10 (2006.01); A61P 5/00 (2006.01); A61P 17/00 (2006.01); A61P 19/10 (2006.01); A61P 25/00 (2006.01); A61P 25/28 (2006.01); A61P 43/00 (2006.01); C07K 14/65 (2006.01)
CPC (source: EP)
A61P 3/08 (2017.12); A61P 3/10 (2017.12); A61P 5/00 (2017.12); A61P 17/00 (2017.12); A61P 19/10 (2017.12); A61P 25/00 (2017.12); A61P 25/28 (2017.12); A61P 43/00 (2017.12); C07K 14/65 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
See references of WO 9739032A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9739032 A1 19971023; AU 2676297 A 19971107; CA 2224859 A1 19971023; EP 0854884 A1 19980729; JP H11508608 A 19990727; MX 9710291 A 19980830
DOCDB simple family (application)
US 9706503 W 19970417; AU 2676297 A 19970417; CA 2224859 A 19970417; EP 97918725 A 19970417; JP 53739897 A 19970417; MX 9710291 A 19971217